Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...

To our immune system, naked RNA is a sign of a viral or bacterial invasion and must be attacked. But our own cells also have ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

The US Food and Drug Administration (FDA) has approved Dawnzera (donidalorsen) for prophylaxis to prevent attacks of ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved ...